

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.38582652 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.38582652 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.48319643 |
| 4 | actin-mediated cell contraction (GO:0070252) | 7.40800400 |
| 5 | skeletal muscle contraction (GO:0003009) | 7.28902955 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 6.53358685 |
| 7 | sarcomere organization (GO:0045214) | 6.40059580 |
| 8 | striated muscle contraction (GO:0006941) | 5.72966244 |
| 9 | myofibril assembly (GO:0030239) | 5.70962352 |
| 10 | creatine metabolic process (GO:0006600) | 5.52999799 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.30056772 |
| 12 | actin filament-based movement (GO:0030048) | 5.13616960 |
| 13 | regulation of relaxation of muscle (GO:1901077) | 5.02657692 |
| 14 | muscle cell fate commitment (GO:0042693) | 4.94851940 |
| 15 | cardiac myofibril assembly (GO:0055003) | 4.94112711 |
| 16 | skeletal muscle fiber development (GO:0048741) | 4.86963115 |
| 17 | cardiac muscle contraction (GO:0060048) | 4.72193083 |
| 18 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.68558609 |
| 19 | response to muscle activity (GO:0014850) | 4.65921005 |
| 20 | response to inactivity (GO:0014854) | 4.58455473 |
| 21 | skeletal muscle adaptation (GO:0043501) | 4.43768736 |
| 22 | myotube cell development (GO:0014904) | 4.21717044 |
| 23 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.21656265 |
| 24 | muscle organ morphogenesis (GO:0048644) | 4.18545292 |
| 25 | actomyosin structure organization (GO:0031032) | 4.14115995 |
| 26 | muscle contraction (GO:0006936) | 3.94998634 |
| 27 | striated muscle atrophy (GO:0014891) | 3.86908121 |
| 28 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.86278515 |
| 29 | ubiquinone biosynthetic process (GO:0006744) | 3.85303943 |
| 30 | muscle tissue morphogenesis (GO:0060415) | 3.81299018 |
| 31 | regulation of actin filament-based movement (GO:1903115) | 3.80526295 |
| 32 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.71980124 |
| 33 | NADH metabolic process (GO:0006734) | 3.69672234 |
| 34 | positive regulation of myotube differentiation (GO:0010831) | 3.59059931 |
| 35 | muscle fiber development (GO:0048747) | 3.56710255 |
| 36 | muscle system process (GO:0003012) | 3.56378606 |
| 37 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53886694 |
| 38 | glycogen biosynthetic process (GO:0005978) | 3.52951887 |
| 39 | glucan biosynthetic process (GO:0009250) | 3.52951887 |
| 40 | striated muscle adaptation (GO:0014888) | 3.48982633 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 3.46897799 |
| 42 | muscle atrophy (GO:0014889) | 3.44017870 |
| 43 | adult heart development (GO:0007512) | 3.43604556 |
| 44 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.41704737 |
| 45 | negative regulation of cell size (GO:0045792) | 3.40494833 |
| 46 | heart process (GO:0003015) | 3.40189223 |
| 47 | heart contraction (GO:0060047) | 3.40189223 |
| 48 | gluconeogenesis (GO:0006094) | 3.37438329 |
| 49 | muscle cell cellular homeostasis (GO:0046716) | 3.34536624 |
| 50 | glycogen catabolic process (GO:0005980) | 3.32147814 |
| 51 | ubiquinone metabolic process (GO:0006743) | 3.30050480 |
| 52 | striated muscle hypertrophy (GO:0014897) | 3.28407746 |
| 53 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.27786233 |
| 54 | mitochondrial fusion (GO:0008053) | 3.27485528 |
| 55 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.18945190 |
| 56 | skeletal muscle tissue development (GO:0007519) | 3.18912241 |
| 57 | tricarboxylic acid cycle (GO:0006099) | 3.17750532 |
| 58 | muscle organ development (GO:0007517) | 3.13466656 |
| 59 | muscle structure development (GO:0061061) | 3.08915280 |
| 60 | regulation of striated muscle contraction (GO:0006942) | 3.07191271 |
| 61 | hexose biosynthetic process (GO:0019319) | 3.06566760 |
| 62 | striated muscle cell development (GO:0055002) | 3.05684363 |
| 63 | plasma membrane repair (GO:0001778) | 3.02926009 |
| 64 | muscle adaptation (GO:0043500) | 3.02662876 |
| 65 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.01649246 |
| 66 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.01083135 |
| 67 | negative regulation of necroptotic process (GO:0060546) | 2.96771844 |
| 68 | muscle hypertrophy (GO:0014896) | 2.96283121 |
| 69 | DNA replication checkpoint (GO:0000076) | 2.92903699 |
| 70 | pseudouridine synthesis (GO:0001522) | 2.92610927 |
| 71 | glucan catabolic process (GO:0009251) | 2.92205246 |
| 72 | regulation of the force of heart contraction (GO:0002026) | 2.90390930 |
| 73 | iron-sulfur cluster assembly (GO:0016226) | 2.85868168 |
| 74 | metallo-sulfur cluster assembly (GO:0031163) | 2.85868168 |
| 75 | cardiac muscle cell development (GO:0055013) | 2.85667308 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 2.84756109 |
| 77 | transcription from mitochondrial promoter (GO:0006390) | 2.81194494 |
| 78 | protein insertion into membrane (GO:0051205) | 2.79487111 |
| 79 | positive regulation of cation channel activity (GO:2001259) | 2.78386851 |
| 80 | carnitine shuttle (GO:0006853) | 2.77902604 |
| 81 | oxidative phosphorylation (GO:0006119) | 2.77327241 |
| 82 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.77319774 |
| 83 | response to activity (GO:0014823) | 2.75311941 |
| 84 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.71414508 |
| 85 | monosaccharide biosynthetic process (GO:0046364) | 2.70336047 |
| 86 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.67337505 |
| 87 | skeletal muscle cell differentiation (GO:0035914) | 2.67199823 |
| 88 | regulation of mitochondrial translation (GO:0070129) | 2.66621994 |
| 89 | regulation of ATPase activity (GO:0043462) | 2.65282399 |
| 90 | regulation of ATP catabolic process (GO:1903289) | 2.65282399 |
| 91 | quinone biosynthetic process (GO:1901663) | 2.64370958 |
| 92 | regulation of cell communication by electrical coupling (GO:0010649) | 2.63680319 |
| 93 | regulation of membrane repolarization (GO:0060306) | 2.63024596 |
| 94 | mitochondrial genome maintenance (GO:0000002) | 2.62663268 |
| 95 | muscle cell development (GO:0055001) | 2.60884943 |
| 96 | cellular polysaccharide catabolic process (GO:0044247) | 2.60065654 |
| 97 | mitochondrial RNA metabolic process (GO:0000959) | 2.59861803 |
| 98 | cardiac cell development (GO:0055006) | 2.58338465 |
| 99 | fatty acid transmembrane transport (GO:1902001) | 2.55263494 |
| 100 | striated muscle tissue development (GO:0014706) | 2.55170631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.69947997 |
| 2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.89564502 |
| 3 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.85120095 |
| 4 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.74252516 |
| 5 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.70119345 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.46483774 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.31668338 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.31297009 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28681626 |
| 10 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.27676531 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.19714467 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.12464460 |
| 13 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.10329952 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09482884 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.02538518 |
| 16 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.01407902 |
| 17 | P68_20966046_ChIP-Seq_HELA_Human | 1.99659747 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.95777678 |
| 19 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.88468363 |
| 20 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.79825300 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79505625 |
| 22 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.72297939 |
| 23 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.70680674 |
| 24 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.68396287 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.67795026 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.65349020 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64715957 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64128835 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.61950504 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61640931 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.61463304 |
| 32 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58228645 |
| 33 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.57371224 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.56663956 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55423839 |
| 36 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.53323503 |
| 37 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.53227257 |
| 38 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.52068795 |
| 39 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.51628737 |
| 40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.50467665 |
| 41 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.48213348 |
| 42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.45089356 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44425260 |
| 44 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.43159355 |
| 45 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.42336542 |
| 46 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.42334679 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41653919 |
| 48 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.41497395 |
| 49 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.41468810 |
| 50 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.40593044 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39525386 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.39499015 |
| 53 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.38627876 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35153178 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34823018 |
| 56 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34686890 |
| 57 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34058750 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33746229 |
| 59 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33176630 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32960923 |
| 61 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.30294959 |
| 62 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.30021827 |
| 63 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29733142 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.29727929 |
| 65 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27898991 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27343583 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27205929 |
| 68 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.26613514 |
| 69 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.26454265 |
| 70 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.25030355 |
| 71 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.23184056 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22871006 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21712451 |
| 74 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.20720891 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20557598 |
| 76 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19269227 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18867590 |
| 78 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16149524 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15973896 |
| 80 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15952914 |
| 81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15579139 |
| 82 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.13736787 |
| 83 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.13666171 |
| 84 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.13279446 |
| 85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12887319 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12769743 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09614318 |
| 88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09448860 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09334039 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08641097 |
| 91 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.08450716 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07633689 |
| 93 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07243384 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07076619 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06822883 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06332966 |
| 97 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06131359 |
| 98 | MAF_26560356_Chip-Seq_TH1_Human | 1.06109725 |
| 99 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.03433985 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03341778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.20170797 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 5.42164129 |
| 3 | MP0000751_myopathy | 4.95581418 |
| 4 | MP0000749_muscle_degeneration | 4.59209151 |
| 5 | MP0005451_abnormal_body_composition | 4.26415551 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 4.00198273 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.83384953 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.52641800 |
| 9 | MP0004233_abnormal_muscle_weight | 3.46621205 |
| 10 | MP0002106_abnormal_muscle_physiology | 3.15672583 |
| 11 | MP0000759_abnormal_skeletal_muscle | 3.14807199 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.05368826 |
| 13 | MP0005330_cardiomyopathy | 3.00731103 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.99200140 |
| 15 | MP0000747_muscle_weakness | 2.95214773 |
| 16 | MP0002269_muscular_atrophy | 2.82222944 |
| 17 | MP0005369_muscle_phenotype | 2.56277004 |
| 18 | MP0000733_abnormal_muscle_development | 2.39367112 |
| 19 | MP0004130_abnormal_muscle_cell | 2.31982566 |
| 20 | MP0002332_abnormal_exercise_endurance | 2.31697423 |
| 21 | MP0005620_abnormal_muscle_contractility | 2.17463088 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 2.09043336 |
| 23 | MP0004215_abnormal_myocardial_fiber | 2.08181087 |
| 24 | MP0002972_abnormal_cardiac_muscle | 1.92336568 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.62954463 |
| 26 | MP0002127_abnormal_cardiovascular_syste | 1.57859853 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.54542646 |
| 28 | MP0001661_extended_life_span | 1.54273791 |
| 29 | MP0006138_congestive_heart_failure | 1.52838222 |
| 30 | MP0000013_abnormal_adipose_tissue | 1.51226186 |
| 31 | MP0000003_abnormal_adipose_tissue | 1.47461883 |
| 32 | MP0004510_myositis | 1.43052527 |
| 33 | MP0002234_abnormal_pharynx_morphology | 1.42503325 |
| 34 | MP0005670_abnormal_white_adipose | 1.40037354 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.39119826 |
| 36 | MP0003693_abnormal_embryo_hatching | 1.35096741 |
| 37 | MP0005385_cardiovascular_system_phenoty | 1.32921137 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.32921137 |
| 39 | MP0005266_abnormal_metabolism | 1.29380230 |
| 40 | MP0010030_abnormal_orbit_morphology | 1.20380114 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.19184103 |
| 42 | MP0008775_abnormal_heart_ventricle | 1.18888504 |
| 43 | MP0005375_adipose_tissue_phenotype | 1.13745030 |
| 44 | MP0002249_abnormal_larynx_morphology | 1.12440250 |
| 45 | MP0002108_abnormal_muscle_morphology | 1.11522128 |
| 46 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04656382 |
| 47 | MP0001346_abnormal_lacrimal_gland | 1.04537861 |
| 48 | MP0004484_altered_response_of | 1.01185462 |
| 49 | MP0009840_abnormal_foam_cell | 0.99551207 |
| 50 | MP0005666_abnormal_adipose_tissue | 0.98968578 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 0.94576639 |
| 52 | MP0002254_reproductive_system_inflammat | 0.94167120 |
| 53 | MP0003111_abnormal_nucleus_morphology | 0.88936775 |
| 54 | MP0010094_abnormal_chromosome_stability | 0.76834070 |
| 55 | MP0002163_abnormal_gland_morphology | 0.73178559 |
| 56 | MP0003786_premature_aging | 0.70586763 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 0.69751026 |
| 58 | MP0004085_abnormal_heartbeat | 0.69186661 |
| 59 | MP0000266_abnormal_heart_morphology | 0.65511572 |
| 60 | MP0000049_abnormal_middle_ear | 0.65098003 |
| 61 | MP0008058_abnormal_DNA_repair | 0.62358570 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 0.60830290 |
| 63 | MP0003828_pulmonary_edema | 0.60806819 |
| 64 | MP0001727_abnormal_embryo_implantation | 0.60671673 |
| 65 | MP0005076_abnormal_cell_differentiation | 0.59897577 |
| 66 | MP0001730_embryonic_growth_arrest | 0.59307070 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.56336016 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.55957395 |
| 69 | MP0003077_abnormal_cell_cycle | 0.54258226 |
| 70 | MP0008260_abnormal_autophagy | 0.53671365 |
| 71 | MP0008932_abnormal_embryonic_tissue | 0.52777410 |
| 72 | MP0001502_abnormal_circadian_rhythm | 0.51773051 |
| 73 | MP0004043_abnormal_pH_regulation | 0.51495914 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.49340509 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.46347266 |
| 76 | MP0008789_abnormal_olfactory_epithelium | 0.46243982 |
| 77 | MP0003879_abnormal_hair_cell | 0.45588274 |
| 78 | MP0003045_fibrosis | 0.44838535 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 0.44826821 |
| 80 | MP0002971_abnormal_brown_adipose | 0.43041951 |
| 81 | MP0005452_abnormal_adipose_tissue | 0.42706652 |
| 82 | MP0002160_abnormal_reproductive_system | 0.42623648 |
| 83 | MP0003959_abnormal_lean_body | 0.38558540 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.38536498 |
| 85 | MP0000358_abnormal_cell_content/ | 0.36864210 |
| 86 | MP0002114_abnormal_axial_skeleton | 0.36564629 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.36209467 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.35448165 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.35312172 |
| 90 | MP0004197_abnormal_fetal_growth/weight/ | 0.35094685 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.33572202 |
| 92 | MP0008007_abnormal_cellular_replicative | 0.33232861 |
| 93 | MP0000762_abnormal_tongue_morphology | 0.33134539 |
| 94 | MP0001849_ear_inflammation | 0.32370620 |
| 95 | MP0000313_abnormal_cell_death | 0.32249738 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.32001815 |
| 97 | MP0000372_irregular_coat_pigmentation | 0.31962561 |
| 98 | MP0001873_stomach_inflammation | 0.31908959 |
| 99 | MP0005083_abnormal_biliary_tract | 0.31316970 |
| 100 | MP0003984_embryonic_growth_retardation | 0.31145976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.93803761 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.78386308 |
| 3 | Nemaline bodies (HP:0003798) | 8.59493550 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.76666354 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 6.51402920 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 5.29002836 |
| 7 | Myopathic facies (HP:0002058) | 5.28819229 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.27876571 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.93782281 |
| 10 | EMG: myopathic abnormalities (HP:0003458) | 4.72774301 |
| 11 | Distal arthrogryposis (HP:0005684) | 4.58067425 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 4.45313163 |
| 13 | Round ear (HP:0100830) | 4.36260918 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.31779411 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.30391308 |
| 16 | Ulnar deviation of the wrist (HP:0003049) | 4.16403876 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.04203552 |
| 18 | Myoglobinuria (HP:0002913) | 3.93393108 |
| 19 | Rhabdomyolysis (HP:0003201) | 3.84853710 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 3.82250721 |
| 21 | Sudden death (HP:0001699) | 3.77678725 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.70037543 |
| 23 | Subaortic stenosis (HP:0001682) | 3.70037543 |
| 24 | Progressive muscle weakness (HP:0003323) | 3.61038495 |
| 25 | Bundle branch block (HP:0011710) | 3.59689825 |
| 26 | Neck muscle weakness (HP:0000467) | 3.55857014 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.39664845 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.39049899 |
| 29 | Calcaneovalgus deformity (HP:0001848) | 3.32192941 |
| 30 | Increased connective tissue (HP:0009025) | 3.25548051 |
| 31 | Rimmed vacuoles (HP:0003805) | 3.23249613 |
| 32 | Ragged-red muscle fibers (HP:0003200) | 3.10305716 |
| 33 | Deformed tarsal bones (HP:0008119) | 3.09204710 |
| 34 | Bulbar palsy (HP:0001283) | 3.05825271 |
| 35 | Areflexia of lower limbs (HP:0002522) | 3.00815417 |
| 36 | Distal lower limb amyotrophy (HP:0008944) | 3.00772887 |
| 37 | Muscle stiffness (HP:0003552) | 2.99626606 |
| 38 | Ventricular tachycardia (HP:0004756) | 2.96841859 |
| 39 | Malignant hyperthermia (HP:0002047) | 2.94736353 |
| 40 | EMG: neuropathic changes (HP:0003445) | 2.94172298 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 2.85442312 |
| 42 | Absent phalangeal crease (HP:0006109) | 2.78585384 |
| 43 | Generalized muscle weakness (HP:0003324) | 2.77635759 |
| 44 | Frequent falls (HP:0002359) | 2.77600575 |
| 45 | Difficulty climbing stairs (HP:0003551) | 2.73408348 |
| 46 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.65883081 |
| 47 | Dilated cardiomyopathy (HP:0001644) | 2.65856406 |
| 48 | Lipoatrophy (HP:0100578) | 2.64776172 |
| 49 | Limb-girdle muscle atrophy (HP:0003797) | 2.55761671 |
| 50 | Fetal akinesia sequence (HP:0001989) | 2.45309925 |
| 51 | Weak cry (HP:0001612) | 2.40524321 |
| 52 | Fatigable weakness (HP:0003473) | 2.34756115 |
| 53 | Abnormality of the neuromuscular junction (HP:0003398) | 2.34756115 |
| 54 | Myotonia (HP:0002486) | 2.33057606 |
| 55 | Difficulty running (HP:0009046) | 2.30078114 |
| 56 | Muscle fiber atrophy (HP:0100295) | 2.29781959 |
| 57 | Heart block (HP:0012722) | 2.26648803 |
| 58 | Abnormal atrioventricular conduction (HP:0005150) | 2.24479034 |
| 59 | Scapular winging (HP:0003691) | 2.21121871 |
| 60 | Abnormal finger flexion creases (HP:0006143) | 2.20068884 |
| 61 | Exercise intolerance (HP:0003546) | 2.18127891 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15933556 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.14460294 |
| 64 | Gowers sign (HP:0003391) | 2.13868904 |
| 65 | Type 2 muscle fiber atrophy (HP:0003554) | 2.11140348 |
| 66 | Ventricular arrhythmia (HP:0004308) | 2.04787957 |
| 67 | Easy fatigability (HP:0003388) | 2.04543463 |
| 68 | Popliteal pterygium (HP:0009756) | 2.01289519 |
| 69 | Lower limb amyotrophy (HP:0007210) | 2.00328857 |
| 70 | Waddling gait (HP:0002515) | 1.99934622 |
| 71 | Spinal rigidity (HP:0003306) | 1.93828364 |
| 72 | Muscular dystrophy (HP:0003560) | 1.89917501 |
| 73 | Slender build (HP:0001533) | 1.85306380 |
| 74 | Supraventricular tachycardia (HP:0004755) | 1.84586271 |
| 75 | Stridor (HP:0010307) | 1.84485616 |
| 76 | Left ventricular hypertrophy (HP:0001712) | 1.81394809 |
| 77 | Abnormality of the calcaneus (HP:0008364) | 1.80814063 |
| 78 | Hip contracture (HP:0003273) | 1.79561735 |
| 79 | Type II lissencephaly (HP:0007260) | 1.79057661 |
| 80 | Severe muscular hypotonia (HP:0006829) | 1.77953856 |
| 81 | Supraventricular arrhythmia (HP:0005115) | 1.75288373 |
| 82 | Atrial fibrillation (HP:0005110) | 1.75195330 |
| 83 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.73879489 |
| 84 | Congenital malformation of the right heart (HP:0011723) | 1.73726999 |
| 85 | Double outlet right ventricle (HP:0001719) | 1.73726999 |
| 86 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.71124235 |
| 87 | Primary atrial arrhythmia (HP:0001692) | 1.69073436 |
| 88 | Syncope (HP:0001279) | 1.67402555 |
| 89 | Large for gestational age (HP:0001520) | 1.67148112 |
| 90 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.66400542 |
| 91 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.65795926 |
| 92 | Abnormality of the foot musculature (HP:0001436) | 1.63006227 |
| 93 | Prolonged QT interval (HP:0001657) | 1.61554276 |
| 94 | Hyperkalemia (HP:0002153) | 1.59527774 |
| 95 | Lactic acidosis (HP:0003128) | 1.57947385 |
| 96 | Achilles tendon contracture (HP:0001771) | 1.57643780 |
| 97 | Increased serum lactate (HP:0002151) | 1.55966862 |
| 98 | Metatarsus adductus (HP:0001840) | 1.55287450 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.53327267 |
| 100 | Hypoplastic heart (HP:0001961) | 1.53093678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.52137866 |
| 2 | TTN | 4.74984578 |
| 3 | PHKG2 | 4.27031156 |
| 4 | PHKG1 | 4.27031156 |
| 5 | TRIB3 | 4.01393429 |
| 6 | MUSK | 2.81585144 |
| 7 | IRAK3 | 2.56874849 |
| 8 | EEF2K | 2.24944250 |
| 9 | NME1 | 2.23557584 |
| 10 | TLK1 | 2.15072390 |
| 11 | MAPKAPK3 | 2.13166161 |
| 12 | MAP2K3 | 2.02330123 |
| 13 | SMG1 | 1.99542970 |
| 14 | BCKDK | 1.91576478 |
| 15 | MAPK12 | 1.78951447 |
| 16 | ICK | 1.75448692 |
| 17 | VRK2 | 1.63926519 |
| 18 | STK16 | 1.55435808 |
| 19 | PIK3CG | 1.55175961 |
| 20 | MAPK11 | 1.50695546 |
| 21 | PINK1 | 1.44150487 |
| 22 | NME2 | 1.43294604 |
| 23 | ARAF | 1.34729754 |
| 24 | BUB1 | 1.30413347 |
| 25 | SIK1 | 1.29400315 |
| 26 | AKT2 | 1.11190560 |
| 27 | MAP3K11 | 1.06654146 |
| 28 | DMPK | 1.04104203 |
| 29 | LIMK1 | 1.00565718 |
| 30 | ZAK | 0.99776328 |
| 31 | MAP3K7 | 0.99583962 |
| 32 | CDK12 | 0.97205109 |
| 33 | TAOK2 | 0.95302318 |
| 34 | MAP2K6 | 0.93528251 |
| 35 | MAP2K2 | 0.89403547 |
| 36 | IRAK2 | 0.88442993 |
| 37 | IRAK4 | 0.87512380 |
| 38 | PIM2 | 0.85289374 |
| 39 | BRAF | 0.83109910 |
| 40 | TBK1 | 0.81505342 |
| 41 | MOS | 0.76873808 |
| 42 | PRKAA1 | 0.75760521 |
| 43 | PRKCI | 0.74216780 |
| 44 | TESK1 | 0.73907682 |
| 45 | MAP3K3 | 0.72375455 |
| 46 | RPS6KA6 | 0.71964074 |
| 47 | RPS6KL1 | 0.71478781 |
| 48 | RPS6KC1 | 0.71478781 |
| 49 | MAP3K13 | 0.71197103 |
| 50 | PRKD3 | 0.70697268 |
| 51 | TRPM7 | 0.69995010 |
| 52 | IKBKB | 0.69979313 |
| 53 | TESK2 | 0.69234099 |
| 54 | AURKA | 0.68973698 |
| 55 | RPS6KA2 | 0.60096076 |
| 56 | TAOK1 | 0.59310855 |
| 57 | ERN1 | 0.57867898 |
| 58 | MAPK4 | 0.57110786 |
| 59 | PRKAA2 | 0.56888668 |
| 60 | CHEK2 | 0.55874327 |
| 61 | CDK7 | 0.53414133 |
| 62 | DAPK3 | 0.52898003 |
| 63 | CAMK2G | 0.52677965 |
| 64 | ILK | 0.52183020 |
| 65 | CCNB1 | 0.51582395 |
| 66 | MTOR | 0.50073777 |
| 67 | MAP2K1 | 0.48519301 |
| 68 | ABL2 | 0.48373733 |
| 69 | CAMK2D | 0.48246132 |
| 70 | CDK4 | 0.47961657 |
| 71 | RPS6KA1 | 0.47733086 |
| 72 | PKN1 | 0.46879859 |
| 73 | PDPK1 | 0.46725763 |
| 74 | PDK2 | 0.46001313 |
| 75 | RPS6KB2 | 0.45565479 |
| 76 | PRKD2 | 0.45233492 |
| 77 | CAMK4 | 0.45090670 |
| 78 | TNK2 | 0.44521456 |
| 79 | CHUK | 0.42612893 |
| 80 | MAP3K8 | 0.40119151 |
| 81 | MAP3K1 | 0.39539528 |
| 82 | STK4 | 0.39083024 |
| 83 | CDC42BPA | 0.38408941 |
| 84 | RPS6KA5 | 0.36723912 |
| 85 | DYRK1B | 0.36395386 |
| 86 | NEK1 | 0.36306010 |
| 87 | CSNK1G3 | 0.34136712 |
| 88 | PRPF4B | 0.33826416 |
| 89 | DAPK1 | 0.33661648 |
| 90 | MAPKAPK2 | 0.30502190 |
| 91 | PKN2 | 0.30479938 |
| 92 | CDK8 | 0.30015631 |
| 93 | NEK9 | 0.29293609 |
| 94 | SIK2 | 0.29268525 |
| 95 | MAP2K4 | 0.29166788 |
| 96 | DYRK3 | 0.26050958 |
| 97 | KDR | 0.25972124 |
| 98 | EPHA2 | 0.25944837 |
| 99 | IRAK1 | 0.25400755 |
| 100 | MAP3K10 | 0.25351076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.75952220 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 4.12805311 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.66574904 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.46182875 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.02408238 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.82006798 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.78963122 |
| 8 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.92389015 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 1.90131849 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.85258033 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 1.82915055 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.78417062 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78323831 |
| 14 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.75650794 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.73708664 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68337792 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.64643126 |
| 18 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.63169017 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.59209772 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.54829519 |
| 21 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.39523078 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38581296 |
| 23 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.38577643 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.34353084 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34095554 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.28549333 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.26823216 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.23755479 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20634542 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.19976344 |
| 31 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17706540 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.17551191 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17054262 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14913598 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14009558 |
| 36 | Insulin resistance_Homo sapiens_hsa04931 | 1.12104743 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08004958 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.07744911 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06273842 |
| 40 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97842456 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96278857 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95292508 |
| 43 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.93055953 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90963194 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89984615 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 0.85935468 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 0.85396098 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84995260 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84837958 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81370993 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81291661 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80539852 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79159345 |
| 54 | RNA transport_Homo sapiens_hsa03013 | 0.78963752 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77818790 |
| 56 | Proteasome_Homo sapiens_hsa03050 | 0.75745662 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75509169 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.74843778 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73618551 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.73029478 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72737435 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72272353 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69552867 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68996326 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66935540 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65252168 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63158424 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62591557 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62578145 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59363253 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58105218 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.58008485 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54322038 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51301099 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50011358 |
| 76 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48969542 |
| 77 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46619997 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45826819 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.44578206 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43470333 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.42995332 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42336682 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41421008 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38740310 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38530599 |
| 86 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.38275456 |
| 87 | Cell cycle_Homo sapiens_hsa04110 | 0.34687901 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34277923 |
| 89 | Ribosome_Homo sapiens_hsa03010 | 0.33399344 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32947014 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30614667 |
| 92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30177218 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29522707 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28894303 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28554747 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28386929 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.26661997 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26016202 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25966435 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.25639704 |

